Ruthenium-Based Small-Molecule Complexes: A Promising Approach for Drug Discovery

Abstract

The paradigm of cancer treatment has been shifting from traditional approaches to metal-based therapies; however, achieving effective and targeted treatments remains a significant challenge. The journey of metal-based drugs began with the serendipitous discovery of cisplatin, which paved the way for the development of various platinum derivatives. Additionally, other metals, such as ruthenium (Ru), nickel (Ni), zinc (Zn), and copper (Cu), have been explored for their therapeutic potential. Among these, ruthenium-based complexes stand out due to their unique redox properties, high selectivity, and remarkable chelation capabilities, making them promising candidates for cancer therapy. This Account aims to provide a comprehensive overview of the journey of ruthenium-based metal complexes, their current status, and their pharmacological and chemical classification. These pharmacophores enable the selective delivery of cytotoxic payloads to cancer cells while sparing healthy cells. Notably, the ruthenium complex IT-139 (formerly NKP-1339) has demonstrated significant promise in clinical studies for various cancer types, exhibiting a lower toxicity than platinum-based therapies. The Account also highlights other ruthenium-based complexes and their advances. It aims to provide readers with a detailed understanding of the role of ruthenium in metal-based drug development, its mechanisms of action, and its potential applications in personalized cancer treatments. This exploration underscores the potential of ruthenium complexes, both with and without active molecules, to emerge as safe and effective therapeutic candidates in clinical oncology.

1 Introduction

2 Importance of Ruthenium Metal and its Complexes

3 Synthesis of Ruthenium Complexes

4 Classification of Ruthenium Complex Antitumor Drugs Based on their Mode of Action

5 Classification of Ruthenium Complex Antitumor Drugs Based on their Structure and the Oxidation State of Ruthenium

6 Current Status of Drug Clinical Trials

7 Status and Applications of Metals Other than Ruthenium

8 Conclusion

Key words

ruthenium complexes - metal-based pharmacophores - cancer therapy - NKP-1339 - redox activity - medicinal chemistry

Publication History

Received: 06 October 2024

Accepted after revision: 11 December 2024

Article published online:
06 March 2025

• References

• 1 Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Adv. Drug Deliv. Rev. 1997; 23: 3
• 2 Drews J. Science 2000; 287: 1960
• 3 Hann MM, Oprea TI. Curr. Opin. Chem. Biol. 2004; 8: 255
• 4 Copeland RA. Nat. Rev. Drug Discovery 2016; 15: 87
• 5 Macarrón R, Banks MN, Bojanic D, Burns DJ, Cirovic DA, Garyantes T, Green DV, Hertzberg RP, Janzen WP, Paslay JW, Schopfer U, Sittampalam GS. Nat. Rev. Drug Discovery 2011; 10: 188
• 6 Duo L, Liu Y, Ren J, Tang B, Hirst JD. Expert Opin. Drug Discovery 2024; 19: 933
• 7 Blanco-Gonzáles A, Cabezón A, Seco-Gonzáles A, Conde-Torres D, Antelo-Riveiro P, Piñeiro Á, Garcia-Fandino R. Pharmaceuticals 2023; 16: 891
• 8 Askr H, Elgeldawi E, Ella HA, Elshaier YA. A. M, Gomaa MM, Hassanien A. Artif. Intell. Rev. 2023; 56: 5975
• 9 Abdolmaleki S, Aliabadi A, Khaksar S. Coord. Chem. Rev. 2024; 501: 215579
• 10 Adhikari S, Nath P, Das A, Datta A, Baildya N, Duttaroy AK, Pathak S. Biomed. Pharmacother. 2024; 171: 116211
• 11 Lainé A.-L, Passirani C. Curr. Opin. Pharmacol. 2012; 12: 420
• 12 Sava G, Bergamo A, Zorzet S, Gava B, Casarsa C, Cocchietto M, Furlani A, Scarcia V, Serli B, Iengo E, Alessio E, Mestroni G. Eur. J. Cancer 2002; 38: 427
• 13 Alessio E. Eur. J. Inorg. Chem. 2017; 1549
• 14 Simpson PV, Desai NM, Casari I, Massi M, Falasca M. Future Med. Chem. 2019; 11: 119
• 15 Lin K, Zhao Z.-Z, Bo H.-B, Hao X.-J, Wang J.-Q. Front. Pharmacol. 2018; 9: 1323
• 16 Rosenberg B, VanCamp L, Trosko JE, Mansour VH. Nature 1969; 222: 385
• 17 Dasari S, Tchounwou PB. Eur. J. Pharmacol. 2014; 740: 364
• 18 Florea A.-M, Büsselberg D. Cancers 2011; 3: 1351
• 19 Kelland L. Nat. Rev. Cancer 2007; 7: 573
• 20 Alessio E, Mestroni G, Bergamo A, Sava G. Curr. Top. Med. Chem. 2004; 4: 1525
• 21 Mahmud KM, Niloy MS, Shakil MS, Islam MA. Pharmaceutics 2021; 13: 1295
• 22 Fricker SP. Dalton Trans. 2007; 4903
• 23 Casini A, Pöthig A. ACS Cent. Sci. 2024; 10: 242
• 24 Boros E, Dyson PJ, Gasser G. Chem 2020; 6: 41
• 25 Claudel M, Schwarte JV, Fromm KM. Chemistry 2020; 2: 849
• 26 Mertens RT, Gukathasan S, Arojojoye AS, Olelewe C, Awuah SG. Chem. Rev. 2023; 123: 6612
• 27 Justi FV. G, Matos GA, de Sá Roriz Caminha J, Rodrigues Roque CR, Muniz Carvalho E, Soares Campelo MW, Belayev L, Gonzaga de França Lopes L, Barreto Oriá R. J. Pharmacol. Exp. Ther. 2022; 380: 47
• 28 Nitin V, Anand T, Singh CK, Sodhi KK. J. Organomet. Chem. 2024; 1022: 123389
• 29 Jayakumar T, Sheu J.-R, Hsia C.-W, Bhavan PS, Chang C.-C. Appl. Sci. 2021; 11: 10092
• 30 Yang M, Bierbach U. Eur. J. Inorg. Chem. 2017; 1561
• 31 Levina A, Mitra A, Lay PA. Metallomics 2009; 1: 458
• 32 Richmond E, Moran J. Synthesis 2017; 50: 499
• 33 Junaid M, Alam MJ, Hossain MK, Halim MA, Ullah MO. In Silico Pharmacol. 2018; 6: 6
• 34 Mouriño V, Cattalini JP, Boccaccini AR. J. R. Soc. Interface 2012; 9: 401
• 35 Benedetti BT, Peterson EJ, Kabolizadeh P, Martínez A, Kipping R, Farrell NP. Mol. Pharmaceutics 2011; 8: 940
• 36 Huynh M, Vinck R, Gibert B, Gasser GS. Adv. Mater. 2024; 36: 2311437
• 37 Yano S, Ohi H, Ashizaki M, Obata M, Mikata Y, Tanaka R, Nishioka T, Kinoshita I, Sugai Y, Okura I, Ogura S, Czaplewska JA, Gottschaldt M, Schubert US, Funabiki T, Morimoto K, Nakai M. Chem. Biodivers. 2012; 9: 1903
• 38 Villarreal W, Colina-Vegas L, Rodrigues de Oliveira C, Tenorio JC, Ellena J, Gozzo FC, Cominetti MR, Ferreira AG, Barbosa Ferreira MA, Navarro M, Batista AA. Inorg. Chem. 2015; 54: 11709
• 39 Johnstone TC, Wilson JJ, Lippard SJ. Inorg. Chem. 2013; 52: 12234
• 40 Freiesleben D, Polborn K, Robl C, Sunkel K, Beck W. Can. J. Chem. 1995; 73: 1164
• 41 Milović NM, Dutcǎ LM, Kostić NM. Inorg. Chem. 2003; 42: 4036
• 42 Singh RV, Fahmi N, Biyala MK. J. Iran. Chem. Soc. 2005; 2: 40
• 43 Kostova I. Curr. Med. Chem. 2006; 13: 1085
• 44 Bashir M, Mantoo IA, Arjmand F, Tabassum S, Yousuf I. Coord. Chem. Rev. 2023; 487: 215169
• 45 Sonkar C, Sarkar S, Mukhopadhyay S. RSC Med. Chem. 2022; 13: 22
• 46 Antonarakis ES, Emadi A. Cancer Chemother. Pharmacol. 2010; 66: 1
• 47 Zeng L, Gupta P, Chen Y, Wang E, Ji L, Chao H, Chen Z.-S. Chem. Soc. Rev. 2017; 46: 5771
• 48 Sava G. In Metal Compounds in Cancer Therapy. Fricker S. Springer; Dordrecht: 1994: 65
• 49 Clarke MJ. Coord. Chem. Rev. 2002; 232: 69
• 50 Purohit P. Curr. Org. Chem. 2023; 27: 55
• 51 Pal M, Purohit P, Upadhyay P. Lett. Org. Chem. 2022; 19: 520
• 52 Arockiam PB, Bruneau C, Dixneuf PH. Chem. Rev. 2012; 112: 5879
• 53 Sava G, Capozzi I, Clerici K, Gagliardi G, Alessio EN, Mestroni G. Clin. Exp. Metastasis 1998; 16: 371
• 54 Kratz F, Keppler BK, Hartmann M, Messori L, Berger MR. Met. Based Drugs 1996; 3: 15
• 55 Kandioller W, Hartinger CG, Nazarov AA, Kasser J, John R, Jakupec MA, Arion VB, Dyson PJ, Keppler BK. J. Organomet. Chem. 2009; 694: 922
• 56 Zeglis BM, Pierre VC, Barton JK. Chem. Commun. 2007; 44: 4565
• 57 Sava G, Pacor S, Bregant F, Ceschia V, Mestroni G. Anti-Cancer Drugs 1990; 1: 99
• 58 Sole R, Bortoluzzi M, Spannenberg A, Tin S, Beghetto V, de Vries JG. Dalton Trans. 2019; 48: 13580
• 59 Jakubaszek M, Goud B, Ferrari S, Gasser G. Chem. Commun. 2018; 54: 13040
• 60 Porwal P, Kundu BK, Mukhopadhyay S. Coord. Chem. Rev. 2021; 448: 214169
• 61 Artner C, Holtkamp HU, Hartinger CG, Meier-Menches SM. J. Inorg. Biochem. 2017; 177: 322
• 62 Śpiewak K, Świątek S, Jachimska B, Brindell M. New J. Chem. 2019; 43: 11296
• 63 Zhang C, Zeng C.-C, Lai S.-H, Xing D.-G, Li W, Han B.-J, Liu Y.-J. Polyhedron 2016; 106: 115
• 64 Kar B, Das U, Roy N, Paira P. Coord. Chem. Rev. 2023; 474: 214860
• 65 Machado JF, Machuqueiro M, Marques F, Robalo MP, Piedade MF. M, Garcia MH, Correia JD. G, Morais TS. Dalton Trans. 2020; 49: 5974
• 66 Sava G, Zorzet S, Turrin C, Vita F, Soranzo M, Zabucchi G, Cocchietto M, Bergamo A, DiGiovine S, Pezzoni G, Sartor L, Garbisa S. Clin. Cancer Res. 2003; 9: 1898
• 67 Du J, Kang Y, Zhao Y, Zheng W, Zhang Y, Lin Y, Wang Z, Wang Y, Luo Q, Wu K, Wang F. Inorg. Chem. 2016; 55: 4595
• 68 Zhao Y, Kang Y, Xu F, Zheng W, Luo Q, Zhang Y, Jia F, Wang F. Adv. Inorg. Chem. 2020; 75: 257
• 69 Gaur R, Mishra L. In Ruthenium Chemistry. Mishra AK, Mishra L. Pan Stanford Publishing; Singapore: 2018. Chap. 10, 337
• 70 Mestroni G, Alessio E, Sava G, Pacor S, Coluccia M, Boccarelli A. Met. Based Drugs 1994; 1: 41
• 71 Goswami S, Chakravarty AR, Chakravorty A. Inorg. Chem. 1981; 20: 2246
• 72 Khanvilkar P, Pulipaka R, Shirsath K, Devkar R, Chakraborty D. J. Coord. Chem.. 2019; 18-72: 2617
• 73 Ji L, Zheng W, Lin Y, Wang X, Lü S, Hao X, Luo Q, Li X, Yang L, Wang F. Eur. J. Med. Chem. 2014; 77: 110
• 74 Trondl R, Heffeter PR, Kowol CR, Jakupec MA, Berger W, Keppler BK. Chem. Sci. 2014; 5: 2925
• 75 Liang L, Wu X, Shi C, Wen H, Wu S, Chen J, Huang C, Wang Y, Liu Y. J. Inorg. Biochem. 2022; 236: 111963
• 76 Chen J, Tao Q, Wu J, Wang M, Su Z, Qian Y, Yu T, Wang Y, Xue X, Liu H.-K. J. Inorg. Biochem. 2020; 210: 111132
• 77 Li Y.-L, Zhu X.-M, Chen N.-F, Chen S.-T, Yang Y, Liang H, Chen Z.-F. Eur. J. Med. Chem. 2022; 236: 114312
• 78 Notaro A, Jakubaszek M, Koch S, Rubbiani R, Dömötör O, Enyedy ÉA, Dotou M, Bedioui F, Tharaud M, Goud B, Ferrari EA, Alessio E, Gasser G. Chem. Eur. J. 2020; 26: 4997
• 79 Licona C, Delhorme JB, Riegel G, Vidimar V, Cerón-Camacho R, Boff B, Venkatasamy A, Tomasetto C, da Silva Figueiredo Celestino Gomes P, Rognan D, Freund J.-N, Le Lagadec R, Pfeffer M, Gross I, Mellitzer G, Gaiddon C. Inorg. Chem. Front. 2020; 7: 678
• 80 Chen D, Guo S, Tang X, Rong Y, Bo H, Shen H, Zhao Z, Qiao A, Shen J, Wang J. J. Inorg. Biochem. 2022; 230: 111749
• 81 Kar B, Das U, De S, Pete SS A. S, Roy N, Ashok Kumar SK, Panda D, Paira P. Dalton Trans. 2021; 50: 10369
• 82 De S, Kumar RS, Gauthaman A, Ashok Kumar SK, Paira P, Moorthy A, Banerjee S. Inorg. Chim. Acta 2021; 515: 120066
• 83 Engelbrecht Z, Roberts KE, Hussan A, Amenuvor A, Cronjé MJ, Darkwa J, Makhubela BC. E, Sitole L. Bioorg. Med. Chem. Lett. 2020; 30: 127492
• 84 Alsaeedi MS, Babgi BA, Abdellattif MH, Jedidi A, Humphrey MG, Hussien MA. Molecules 2020; 26: 76
• 85 Sonkar C, Malviya N, Sinha N, Mukherjee A, Pakhira S, Mukhopadhyay S. BioMetals 2021; 34: 795
• 86 Chen C, Xu C, Li T, Lu S, Luo F, Wang H. Eur. J. Med. Chem. 2020; 203: 112605
• 87 Alkış ME, Keleştemür Ü, Alan Y, Turan N, Barldurun K. J. Mol. Struct. 2021; 1226: 129402
• 88 Parveen S. Appl. Organomet. Chem. 2020; 34: e5687
• 89 Shivakumar M, Pramanik K, Bhattacharyya I, Chakravorty A. Inorg. Chem. 2000; 39: 4332
• 90 Brabec V, Kasparkova J. Coord. Chem. Rev. 2018; 376: 75
• 91 Sadique S, Baqer AA, Salman AW, Iqbal MA, Kadim MM, Jamil F, Majeed A, Manahil S, Altaf A. Rev. Inorg. Chem. 2024; 44: 191
• 92 Adeloye AO, Koudjina S, Kumar V, Tapala KC, Gbenou JD, Chetti P. Dyes Pigm. 2025; 235: 112626
• 93 Lu T.-F, Wang K, Han X, Cui Y, Tao H, He M, Zhang Z, He B. Struct. Chem. 2025;
• 94 Monro S, Colon KL, Yin H, Roque JIII, Kond P, Gujar S, Thummel RP, Lilge L, Cameron CG, McFarland SA. Chem. Rev. 2018; 119: 797
• 95 Rajendiran V, Murali M, Suresh E, Palaniandavar M, Periasamy VS, Akbarsha MA. Dalton Trans. 2008; 2157
• 96 Heinemann F, Karges J, Gasser G. Acc. Chem. Res. 2017; 50: 2727
• 97 Piraux G, Bar L, Abraham M, Lavergne T, Jamet H, Dejeu J, Marcélis L, Defrancq E, Elias B. Chem. Eur. J. 2017; 23: 11872
• 98 Zhang Z, Wu Q, Wu X.-H, Sun F.-Y, Chen L.-M, Chen J.-C, Yang S.-L, Mei W.-J. Eur. J. Med. Chem. 2014; 80: 316
• 99 Jiang J, Teunens T, Tisaun J, Denuit L, Moucheron C. Molecules 2022; 27: 1541
• 100 Palma E, Carvalho J, Cruz C, Paulo A. Pharmaceuticals 2021; 14: 605
• 101 Yuan C, Wang Z, Wang Z, Liu W, Li G, Meng J, Wu R, Wu Q, Wang J, Mei W. Int. J. Mol. Sci. 2022; 24: 203
• 102 Zhu X, Sun Q, Guo X, Liang C, Zhang Y, Huang W, Pei W, Huang Z, Chen L, Chen J. Inorg. Biochem. 2023; 247: 112333
• 103 Chen L, Yu W, Tang H, Zhang S, Wang J, Ouyang Q, Guo M, Zhu X, Huang Z, Chen J. Metallomics 2024; 16: mfae002
• 104 Omae I. Coord. Chem. Rev. 2014; 280: 84
• 105 Solís-Ruiz JA, Barthe A, Riegel G, Saavedra-Díaz RO, Gaiddon C, Le Lagadec R. J. Inorg. Biochem. 2020; 208: 111080
• 106 Elumalai P, Jeong YJ, Park DW, Kim DH, Kim H, Kang SC, Chi K.-W. Dalton Trans. 2016; 45: 6667
• 107 Sikkander AR. M. Biomed. Eng. (Singapore) 2025; 37: 2430003
• 108 https://www.bold-therapeutics.com/news-post?Bold+Therapeutics+Presents+Jaw-Dropping+Interim+Phase+2+Clinical+Data+for+BOLD-100+in+the+Treatment+of+Advanced+Colorectal+Cancer+at+AACR+2023+ (accessed Nov. 29, 2024)
• 109 Trondl R, Heffeter P, Jakupec MA, Berger W, Keppler BK. BMC Pharmacol. Toxicol. 2012; 13: A82
• 110 Saravanaselvam SV, Arulanantham X, Tamilelakkiya M, Sakthivadivel R, Ponnusamy S, Pandi P, Velusamy P, Muthu SE, Kumar KA. J. Mol. Struct. 2025; 1325: 141000
• 111 Wang H, Gan X, Tang Y. Biol. Trace Elem. Res. 2025; 203: 608
• 112 Hassan SS, Aly SA, Ismail RA, Aboelyazed AM, Youssef MH, Abdalla EM. Appl. Organomet. Chem. 2025; 39: e7990
• 113 Alyaninezhad Z, Bekhradnia A, Gorji RZ, Arshadi S, Ahmadi S, Gorji MZ. J. Mol. Struct. 2023; 1275: 134607
• 114 Bonaccorso C, Marzo T, La Mendola D. Pharmaceuticals 2020; 13: 4